Features | Eosinophils ≥500/mm3 N=26 | Eosinophils <500/mm3 N=778 | p Value |
---|---|---|---|
Age, mean (SD) | 45.7 (14.4) | 47.6 (12.5) | 0.64 |
Females, n (%) | 20/26 (76.9) | 598/778 (76.9) | 1 |
DAS28, mean (SD) | 5.2 (0.8) | 5.1 (1.3) | 0.75 |
Patient-assessed VAS disease | 69.0 (23.5) | 59.5 (24.6) | 0.1 |
Morning stiffness | 99.8 (276.9) | 92.8 (182.7) | 0.2 |
HAQ | 1.1 (0.6) | 1.0 (0.7) | 0.1 |
Rheumatoid nodules, n (%) | 1/26 (3.8) | 15/777 (1.9) | 0.41 |
Radiographic changes, n (%) | 4/26 (15.4) | 105/777 (13.5) | 0.77 |
NSAID use, n (%) | 14/25 (56) | 358/699 (51.21) | 0.64 |
Haemoglobin (g/dL), mean (SD) | 12.7 (1.4) | 12.6 (1.7) | 0.74 |
Platelets/mm3, mean (SD) | 3.1×105 (0.7×105) | 3.1×105 (1.0×105) | 0.44 |
Leucocytes/mm3, mean (SD) | 8.6×103 (2.2×103) | 7.5×103 (2.7×103) | 0.007 |
Lymphocytes/mm3, mean (SD) | 2.1×103 (0.7×103) | 1.8×103 (1.7×103) | 0.02 |
Neutrophils/mm3, mean (SD) | 5.3×103 (1.8×103) | 4.9×103 (2.0×103) | 0.20 |
CRP (mg/L), mean (SD) | 20.5 (28.2) | 20.2 (32.6) | 0.93 |
Creatinine (μmol/L), mean (SD) | 71.2 (13.9) | 73.4 (15.3) | 0.36 |
Positive RF, n (%) | 9/26 (34.6) | 329/775 (42.4) | 0.43 |
ACPA >3N, n (%) | 10/26 (38.5) | 316/777 (40.7) | 0.82 |
Bold typeface indicates p≤0.05.
ACPA, anticitrullinated protein antibody; CRP, C reactive protein; DAS, Disease Activity Score; HAQ, health assessment questionnaire; NSAID, non-steroidal anti-inflammatory drug; RF, rheumatoid factor; VAS, visual analogue scale.